SCHEMBL25217065

SCHEMBL25217065

CS(=O)(=O)NCC1CCCCN1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XPNPEP1 Q9NQW7 1/20 0.53
DPP4 P27487 4/20 0.47
PREP P48147 1/20 0.47
FAP Q12884 1/20 0.47
DPP8 Q6V1X1 2/20 0.46
DPP9 Q86TI2 2/20 0.46
DPP7 Q9UHL4 2/20 0.46
CYP2D6 P10635 1/20 0.46
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HRH3 Q9Y5N1 1/20 0.37
MAPT P10636 1/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SLC22A12 Q96S37 1/20 0.35
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21664373 0.80 KDM1A (0.49) XPNPEP1DPP4PREPFAPDPP8
SCHEMBL22370887 0.80 HRH3 (0.40) NPC1RAB9AHRH3MAPTALDH1A1
SCHEMBL22578383 0.80 HRH3 (0.40) NPC1RAB9AHRH3MAPTALDH1A1
SCHEMBL25180293 0.80 HRH3 (0.40) NPC1RAB9AHRH3MAPTALDH1A1
Hydrochloric Acid SCHEMBL29654932 0.79 ALDH1A1 (0.40) NPC1RAB9AHRH3MAPTALDH1A1
SCHEMBL18422980 0.77 CTSL (0.58) DPP4DPP8DPP9DPP7NPC1
SCHEMBL5612256 0.76 DPP4 (0.41) DPP4PREPFAPDPP8DPP9
SCHEMBL15653975 0.76 DAGLB (0.40) NPC1RAB9AMAPTHCRTR2POLB
SCHEMBL3699146 0.76 DAGLB (0.40) NPC1RAB9AMAPTHCRTR2POLB
SCHEMBL3939060 0.76 XPNPEP1 (0.38) XPNPEP1DPP4PREPFAPDPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172932-A1 SUBSTITUTED QUINAZOLINE SULFONAMIDES AS THIOREDOXIN INTERACTING PROTEIN (TXNIP) INHIBITORS SOUTHERN RESEARCH INSTITUTE (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172932-A1 SUBSTITUTED QUINAZOLINE SULFONAMIDES AS THIOREDOXIN INTERACTING PROTEIN (TXNIP) INHIBITORS TXN, TXNL1, TXN2 XPNPEP1 660/4885DPP4 156/4885PREP 1014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.